PT-141 and melanotan-2 libido claims: what TikTok skips

What did @forgedbyolsen actually say?

The creator claimed PT-141 works "on the brain" by hitting melanocortin receptors to increase desire and arousal, calling it "the on switch." They also said melanotan-2 (MT-2) is a "two for one" compound that produces both skin darkening and stronger arousal. Both were framed as research chemicals "for lab rats only" with repeated disclaimers that they are not for humans.

To be clear about what was said: the creator did not recommend dosing, did not claim these are FDA-approved, and did not explicitly tell anyone to inject anything. The "research only" framing is a legal fig leaf that serious researchers find tiresome, but it was stated repeatedly. The core scientific claims, that PT-141 acts on melanocortin receptors and that MT-2 produces both tanning and sexual side effects, are actually grounded in real data.

Does the science back this up?

Mostly, yes, at least on the mechanism side. PT-141, also known as bremelanotide, is an FDA-approved drug. That part was conspicuously absent from this video. Melanotan-2 is a different, unapproved compound with a messier profile.

PT-141 was approved by the FDA in 2019 under the brand name Vyleesi for hypoactive sexual desire disorder in premenopausal women. The pivotal approval trial (Simon et al., 2019, Journal of Sexual Medicine) showed statistically significant improvements in desire scores versus placebo. The mechanism the creator described is accurate: it acts as a melanocortin receptor agonist, primarily at MC3R and MC4R in the central nervous system, not on sex hormones. Kingsberg et al. (2019, Obstetrics and Gynecology) confirmed the CNS-mediated pathway in clinical review.

Melanotan-2 is a different story. It is not approved anywhere and has no completed Phase III clinical trials. Animal studies (van der Ploeg et al., 2002, PNAS) confirmed pro-erectile and pigmentation effects via melanocortin agonism, but human safety data is essentially limited to case reports and small open-label studies.

What did they get wrong (or right)?

The creator got the mechanism right but left out the fact that PT-141 already exists as an FDA-approved prescription drug. That omission matters a lot. Calling Vyleesi a "research chemical" is simply inaccurate, and that framing could push people toward gray-market peptide suppliers instead of a licensed prescriber.

What they got right: the claim that PT-141 "doesn't touch your testosterone" is accurate. It is not a hormonal agent. The melanocortin receptor mechanism they described matches published pharmacology. The characterization of MT-2 as producing both tanning and arousal effects aligns with what animal and limited human data show.

What they got wrong or soft-pedaled: MT-2 carries real risks that did not get a single second of airtime. Case reports have linked unregulated MT-2 use to rapid changes in existing moles, nausea, spontaneous erections, and at least one case of melanoma progression flagged in the literature (Langan et al., 2010, British Medical Journal). Presenting it as a fun "two for one" without that context is irresponsible.

What should you actually know?

If you are experiencing low sexual desire and think a melanocortin-based option might help, there is a legal, supervised path. Bremelanotide (Vyleesi) is FDA-approved, can be prescribed by a licensed provider, and has a documented safety profile from clinical trials. That is a categorically different situation than buying an unregulated peptide online and self-injecting based on a TikTok.

Melanotan-2 is a separate compound that has never cleared clinical trials. The tanning and libido effects are real in the sense that the compound does activate melanocortin receptors, but the risk profile is not well-characterized in humans. Unregulated MT-2 products have no quality controls, and the skin pigmentation effects are not reliably safe for people with existing moles or a history of skin conditions.

• PT-141 (bremelanotide) is FDA-approved as Vyleesi. It is not a research chemical.
• Melanotan-2 is genuinely unapproved and carries documented dermatological risks.
• Neither compound should be self-administered outside of medical supervision.
• The "lab rat" framing does not provide legal or safety protection to the people watching this video.